2023
DOI: 10.1016/j.jcmgh.2023.03.009
|View full text |Cite
|
Sign up to set email alerts
|

PTPN2 Is a Critical Regulator of Ileal Paneth Cell Viability and Function in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 84 publications
0
2
0
Order By: Relevance
“…87 In addition, loss of the functions and mutation of PTPN2, a key regulator to maintain the vitality and functions of PCs, could accelerate the expansion of inflammatory response. 65,88 In summary, the intestinal tract is not as active as it should be in SAP. The weakness of the intestinal mucus layer, the reduced secretion of AMPs, and the increased abundance of pathogenic bacteria in SAP are closely related to the impaired function of PCs.…”
Section: Goblet Cells (Gcs)mentioning
confidence: 97%
See 1 more Smart Citation
“…87 In addition, loss of the functions and mutation of PTPN2, a key regulator to maintain the vitality and functions of PCs, could accelerate the expansion of inflammatory response. 65,88 In summary, the intestinal tract is not as active as it should be in SAP. The weakness of the intestinal mucus layer, the reduced secretion of AMPs, and the increased abundance of pathogenic bacteria in SAP are closely related to the impaired function of PCs.…”
Section: Goblet Cells (Gcs)mentioning
confidence: 97%
“… 63 Current studies have shown that the reduction of Lgr5+ ISCs in response to intestinal injury is accompanied by the increased secretion of stem cell factors and the enhanced ISCs functions, which is associated with the re-entry of PCs into the cell cycle, the loss of the secretory phenotype, and the acquisition of stem cell properties, which contribute to the regeneration of tissues and the response to the inflammation. 64 , 65 The interaction between ISCs and the immune cells represents a promising therapeutic target in the context of SAP-ALI. 66 …”
Section: Composition Of the Intestinal Mucosal Immune Barriermentioning
confidence: 99%